Literature DB >> 21769438

Association of stem-like cells in gender-specific chemoprevention against intestinal neoplasia in MIN mouse.

Seema R Gandhi1, Ashish K Tiwari, Dhananjay P Kunte, Mart Angelo De la Cruz, Yolanda Stypula, Tina Gibson, Jeffrey Brasky, Vadim Backman, Ramesh K Wali, Hemant K Roy.   

Abstract

This study was undertaken to examine the gender-sensitivity and chemopreventive responsiveness of celecoxib on intestinal stem-like cells as a biomarker of colon carcino-genesis, using the MIN mouse model. Male and female MIN mice (6-7-weeks old) were randomized to either control diet or to a diet supplemented with celecoxib (1,500 ppm). The animals were euthanized ten weeks later and the intestines were flushed and opened longitudinally to assess tumor count. Small intestinal segments were formalin-fixed and tissue sections were subjected to immunohistochemical evaluation of DCAMKL1, a known marker of stem-like cells. We found that in animals receiving control (AIN 76A diet) alone, female MIN mice had a higher polyp count than males (52.32 ± 13.89 vs. 35.43 ± 16.05; p<0.0005). However, compared to control diet groups, celecoxib supplementation caused a larger reduction in the number of polyps in females than their male cohorts (6.38 ± 1.43 vs. 12.83 ± 6.74; a reduction of 88% in females to 64% in males). Significant differences (p=0.013) were observed in the number of DCAMKL1-stained cells in the crypts of the wild-type (WT) (10.01 ± 1.07 stem cells per high powered field; HPF) compared to the MIN mice (24.15 ± 8.08 stem cells per HPF), illustrating increased stem-like cells in animals that are more prone to neoplasia. DCAMKL1 labeled stem-like cells were equal in number in the male and female groups receiving the control AIN 76A diet alone (females, 25.73 stem-like cells/HPF); males, 24.15 stem-like cells/HPF). However, females showed a greater reduction in the number of DCAMKL1-labeled stem-like cells with celecoxib supplementation than the respective males (16.63 ± 4.23 vs. 21.56 ± 9.06; a reduction of 35.4% in females to 10.7% in males). We conclude that a higher number of stem-like cells in the uninvolved mucosa paralleled tumorigenesis and mirrored greater chemopreventive responsiveness of female MIN mice compared to males.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769438      PMCID: PMC3557947          DOI: 10.3892/or.2011.1395

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  34 in total

1.  Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

Authors:  U Ladabaum; C L Chopra; G Huang; J M Scheiman; M E Chernew; A M Fendrick
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.

Authors:  Nalú Navarro-Alvarez; Eisaku Kondo; Hironobu Kawamoto; Wael Hassan; Takeshi Yuasa; Yasuhiro Kubota; Masayuki Seita; Hiroyuki Nakahara; Takahiro Hayashi; Yuriko Nishikawa; Reham A R A Hassan; Shahid M Javed; Hirofumi Noguchi; Shinichi Matsumoto; Shuhei Nakaji; Noriaki Tanaka; Naoya Kobayashi; Alejandro Soto-Gutierrez
Journal:  Cell Transplant       Date:  2010-06-29       Impact factor: 4.064

Review 3.  Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story).

Authors:  Robert S Bresalier
Journal:  Curr Opin Gastroenterol       Date:  2007-01       Impact factor: 3.287

4.  Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Authors:  Bernard F Cole; Richard F Logan; Susan Halabi; Robert Benamouzig; Robert S Sandler; Matthew J Grainge; Stanislas Chaussade; John A Baron
Journal:  J Natl Cancer Inst       Date:  2009-02-10       Impact factor: 13.506

5.  Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-alpha gene in rat colon tumors.

Authors:  Michael A Pereira; Lianhui Tao; Wei Wang; Yingzhe Li; Asad Umar; Vernon E Steele; Ronald A Lubet
Journal:  Carcinogenesis       Date:  2004-06-17       Impact factor: 4.944

6.  Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively.

Authors:  Randal May; Sripathi M Sureban; Nguyet Hoang; Terrence E Riehl; Stan A Lightfoot; Rama Ramanujam; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

7.  Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.

Authors:  Joseph E Carpentino; Mark J Hynes; Henry D Appelman; Tong Zheng; Dennis A Steindler; Edward W Scott; Emina H Huang
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

Review 8.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

9.  Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

Authors:  Emina H Huang; Mark J Hynes; Tao Zhang; Christophe Ginestier; Gabriela Dontu; Henry Appelman; Jeremy Z Fields; Max S Wicha; Bruce M Boman
Journal:  Cancer Res       Date:  2009-03-31       Impact factor: 12.701

10.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

Authors:  S E Gabriel; L Jaakkimainen; C Bombardier
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

View more
  1 in total

1.  COX-2 Inhibitors Decrease Expression of PD-L1 in Colon Tumors and Increase the Influx of Type I Tumor-infiltrating Lymphocytes.

Authors:  Denise L Cecil; Ekram A Gad; Lauren R Corulli; Nicholas Drovetto; Ronald A Lubet; Mary L Disis
Journal:  Cancer Prev Res (Phila)       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.